Axsome Therapeutics Inc (NASDAQ:AXSM)
| 64.90 Delayed Data As of 3:59pm ET |  -1.17 / -1.76%Today’s Change | 35.44 Today|||52-Week Range 109.53 | -20.34% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 13.1K | 12.2K | 11.4K | 11.1K | ||
| Operating Expenses | Gross Income | -13.1K | -12.2K | -11.4K | -11.1K | |
| General Expenses | 8.2M | 9.4M | 10.4M | 13.4M | ||
| Research And Development | 6.0M | 7.2M | 7.6M | 11.0M | ||
| Total Operating Expenses | 8.2M | 9.5M | 10.4M | 13.4M | ||
| Non-Operating Expenses | Operating Income | -8.2M | -9.5M | -10.4M | -13.4M | |
| Extraordinary Credit | 15.0K | 102.0K | 0.00 | 0.00 | ||
| Interest Expense On Debt | 270.9K | 248.7K | 218.9K | 314.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -8.5M | -9.6M | -10.6M | -13.8M | |
| Income Taxes | -217.4K | 0.00 | 0.00 | 0.00 | ||
| Net Income | -8.3M | -9.6M | -10.6M | -13.8M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 26.3M | 29.9M | 33.1M | 33.8M | |
| Shares To Calculate EPS Diluted | 26.3M | 29.9M | 33.1M | 33.8M | ||
| Earnings Per Share | EPS | -$0.31 | -$0.32 | -$0.32 | -$0.41 | |
| EPS Diluted | -$0.31 | -$0.32 | -$0.32 | -$0.41 | ||
